Pfizer PAC Political Action Committee Leading the Conversation Pfizer PAC and Corporate Political Contributions Report January 2019–December 2020 Corporate Affairs Government Relations U.S. Government Relations & Pfizer PAC Leading the Conversation and Making an Impact A Message from Sally Susman & Rady Johnson, Co-Chairs, Pfizer PAC We are pleased to share our 2020 election cycle political contributions report, which includes a list of candidates and political committees supported either by Pfizer Inc. or the Pfizer PAC from January 1, 2019 through December 31, 2020. It has been a year like no other, and we are proud of the all the hard work and long hours our colleagues dedicated and continue to dedicate to develop and deliver the first COVID-19 vaccine. As if COVID wasn’t enough, 2020 was also a big election year and Pfizer and the Pfizer PAC continued to support candidates of both political parties who support policies that impact our purpose: Breakthroughs that change patients’ lives. We do not contribute to Presidential candidates or super PACs. In the 2020 cycle, Pfizer PAC and Pfizer Inc. supported 1,842 candidates and multiple political committees at all levels of the government. Forty-nine percent of the Pfizer PAC disbursements in the 2019-2020 cycle went to Republicans and 46% went to Democrats. We continue to advance our purpose to discover and deliver breakthroughs that change patients’ lives, thanks to our PAC members and our Pfizer U.S. Government Relations team, who are on the ground educating and engaging elected officials about Pfizer’s purpose. As Pfizer’s Chief Compliance & Corporate Affairs Officers, we can tell you unequivocally that our decision to contribute to any elected official is made based on ethical, responsible, and just policies that support innovation incentives and patients’ access to breakthrough medicines and vaccines. Our PAC support does not imply an endorsement of a candidate’s position on any social or religious issue. We consider our support of the PAC a vote for Pfizer; we make this vote with the same pride that we do when we show up at the voting booth and vote for candidates who we believe are best for our profession and our families. No breakthrough can get to patients without a favorable regulatory and legislative framework. The PfizerP AC helps ensure that framework is strong. We hope you will take some time to review the report to see which candidates theP AC supported in your state and community. Our priority in 2021 is to help build a constructive discourse in the political and regulatory environment while supporting policies – and policymakers – who share these same ideals. Those policy priorities include improving patient affordability and access, defending against threats to our patents and intellectual property, protecting patients from dangerous insurance barriers and counterfeit medicines, ensuring patients continue to have robust access to innovative medicines in Medicare Part D and keeping an eye on burdensome tax policies. As Pfizer’sP AC Co-Chairs, and through our interactions with elected officials, we see first-hand how decisions are made that impact our ability to bring breakthrough medicines and vaccines to patients and physicians who rely on us every day. We must ensure our voice is heard so that patients can continue to be first in everything we do. Thank you for your support, Sally Susman Rady Johnson Executive Vice President Executive Vice President Chief Corporate Affairs Officer Chief Compliance, Quality & Risk Officer Co-Chair, Pfizer PAC Co-Chair, Pfizer PAC 2 PFIZER PAC Leading the Conversation. What is a PAC? Who Receives PfizerP AC Contributions? PAC stands for Political Action Committee. A political action PfizerP AC is nonpartisan. It supports committee is a government-regulated Democrats and Republicans who organization that anyone can support policies that impact our form to raise money for political purpose: Breakthroughs that change campaign donations. PACs are patients’ lives. From January 2019 formed by individuals, non-profits, through December 2020, PfizerP AC and even many major supported 950 candidates. corporations. When choosing to make a How Does P izer PAC Work? contribution to a candidate, our Government Relations colleagues The Pfizer political action committee, consider candidates’ views and voting Pfizer PAC, is a nonpartisan record on policy issues that impact organization that provides patient access to breakthrough opportunities for employees to medicines and vaccines as well as the participate in the American political impact on our employees and Pfizer process. The Pfizer PAC is an facilities in the candidate’s district or employee-run organization with a state. A complete list of Pfizer PAC and Steering Committee made up of state corporate political contributions Pfizer employees from different for January 2019 – December 2020 is divisions of the company. All included in this report. corporate PACs are funded by voluntary employee contributions. Pfizer PAC is no different; it relies on the participation of Pfizer colleagues. 3 PFIZER PAC & POLITICAL CONTRIBUTIONS GOVERNANCE POLICY Pfizer complies fully with all federal, state, and local laws and reporting requirements governing PAC and corporate political contributions. Pfizer has a Corporate Policy Procedure (#802a) that requires all PAC and corporate political contributions to be compiled and published annually in a report that is made available to employees, shareholders, and the public, and posted on the Company’s website at www.pfizer.com in “Lobbying and Political Contributions” under the “About Pfizer” tab within the “Corporate Governance” section. At the end of each Federal cycle (every two years), the Pfizer PAC is audited by Withum, a certified public accounting and advisory firm. Pfizer also requests that trade associations receiving total payments of $100,000 or more from Pfizer in a given year report the portion of Pfizer dues or payments used for expenditures or contributions that, if made directly by Pfizer, would not be deductible under section 162(e)(1)(B) of the Internal Revenue Code. We are disclosing such information received from our trade associations in this report. Pfizer has a PAC Steering Committee comprised of five colleagues who review and approve all PAC and corporate political contributions on a monthly basis. To ensure adequate representation, Steering Committee members represent different divisions within the Pfizer organization. The PAC Steering Committee evaluates candidates on a basis of their views on issues that impact Pfizer and its colleagues. It also takes note of whether Pfizer facilities or colleagues reside in a candidate’s district or state. In addition, all PAC and corporate contribution requests are shared with the Pfizer Political Contributions Policy Committee for review. The Political Contributions Policy Committee is responsible for governing the Pfizer PAC. Pfizer does not traditionally make contributions to 527 Issue Organizations. If we were asked to make such a contribution, it would have to be reviewed and approved by the Political Contributions Policy Committee and subsequently disclosed in our semi-annual report. Finally, in light of the Supreme Court decision in the Citizens United case, Pfizer has determined that it will not make any direct independent expenditures, a decision which has been discussed at the executive level as well as with the Corporate Governance Committee of our Board. 4 Political Contributions Policy Committee CO CHAIR David Blackwell Rod MacKenzie Sally Susman Senior Director Executive Vice President Executive Vice President Global General Toxicology Chief Development Officer Chief Corporate Affairs Officer Research & Development Global Product Development Group CO CHAIR Josh Brown Rady Johnson Vice President Margaret Madden Executive Vice President State Government Relations Senior Vice President Chief Compliance, Quality Corporate Affairs & Corporate Secretary & Risk Officer Chief Governance Counsel Sheryl Colyer TREASURER Vice President Ed Nowicki Matthew Meehan Human Resources Senior Vice President Director Deputy Chief Compliance Officer U.S. Government Relations Navin Katyal Corporate Compliance Regional President SECRETARY Hospital Business Unit Andrew Schmeltz Barbara Bonfiglio Pfizer Biopharma Group Global President Assistant General Counsel Pfizer Oncology Corporate Governance John Kelly Pfizer Biopharma Group Vice President Quality Operations & EHS Jennifer Walton Pfizer Global Supply Vice President U.S. Government Relations Nick Lagunowich Corporate Affairs Global President Internal Medicine John Young Pfizer Biopharma Group Group President Chief Business Officer Pfizer PAC Steering Committee Leslie Black, DBA Sam Gonzalez Dezarie Mayers Senior Manager Business/Scientific Senior Manager Oncology Training Operations Lead Global Health & Social Impact Global Products Development Jim Cafone Pfizer Oncology Dennis Ryan Vice President Key Account Manager Pfizer Global Supply Mike Hoffman Pfizer Internal Medicine Vice President Richard Dudek Global Procurement Vice President National Sales Pfizer Oncology 5 Pfizer PAC Political Action Committee Leading the Conversation Political Contributions Recipients January 2019 – December 2020 Corporate Affairs Government Relations Pfizer Political Contributions Recipients January 2019 – December 2020 Debt Future State/Office Win Full Name Facility Party District Corp PAC Retirement Election ALABAMA US SENATE Doug Jones D $10,000.00 Sen. Thomas H. Tuberville Up in '26 R $2,500.00 US HOUSE W Rep. Robert Brown Aderholt R 004 $1,000.00 Bradley Roberts Byrne R 001 $2,500.00 W Rep. Terri Andrea Sewell D 007 $6,000.00 STATE ATTORNEY GENERAL AG Steve T. Marshall R $5,000.00 ALASKA US SENATE W Sen. Daniel Scott Sullivan R $5,000.00 ARIZONA US SENATE Martha Elizabeth McSally R $7,500.00 Sen. Kyrsten Sinema Up in ‘24 D $2,500.00 US HOUSE W Rep. Ruben M. Gallego D 007 $2,000.00 W Rep. Ann L. Kirkpatrick D 002 $2,000.00 W Rep. Tom O'Halleran D 001 $4,000.00 W Rep. David Schweikert R 006 $2,000.00 STATE SENATE Sylvia Tenney Allen R 006 $600.00 W Sen. Lela Alston D 024 $600.00 W Sen. Nancy K. Barto R 015 $400.00 W Sen. Sean Bowie D 018 $650.00 W Sen.